Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

208
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
208
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Glaucoma: Overview01:25

Glaucoma: Overview

1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

368
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
368
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

797
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
797

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perceptual Learning Therapy Using RevitalVision in Patching-Failed Amblyopia: Visual Outcomes, Predictors of Response, and Durability.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Gillespie syndrome caused by a novel <i>ITPR1</i> gene variant: a phenotype-genotype correlation.

Ophthalmic genetics·2026
Same author

Association of Autosomal Dominant Snowflake Vitreoretinal Degeneration with Retinoschisis.

Ophthalmology science·2026
Same author

Gelatinous drop-like amyloid in FOXC2 distichiasis syndrome: a case report.

BMC ophthalmology·2026
Same author

Lipemia retinalis: a case study of a rare finding in pediatric retina secondary to diabetes.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Eye care adherence in pediatric and elderly: Understanding and addressing the challenges.

Progress in retinal and eye research·2026

Related Experiment Video

Updated: Mar 22, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K

Pediatric Glaucoma: Pharmacotherapeutic Options.

Monica Samant1,2, Anagha Medsinge1,2,3, Ken K Nischal4,5,6

  • 1Children's Hospital of Pittsburgh of UPMC, Pediatric Ophthalmology, Strabismus, and Adult Motility, 4401 Penn Avenue, Suite 5000, Pittsburgh, PA, 15224, USA.

Paediatric Drugs
|April 21, 2016
PubMed
Summary

Managing childhood glaucoma presents challenges, as many medications are used off-label. Prostaglandin analogs show promise with fewer side effects in pediatric glaucoma treatment.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.7K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.9K

Related Experiment Videos

Last Updated: Mar 22, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.0K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.7K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

1.9K

Area of Science:

  • Ophthalmology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Childhood glaucoma is a significant challenge for pediatric eye care professionals globally.
  • Current pharmacotherapy for pediatric glaucoma lacks regulatory approval and robust clinical trial data.
  • Understanding treatment options is crucial due to varying etiologies and patient ages.

Purpose of the Study:

  • To review available pharmacotherapeutic options for treating glaucoma in children.
  • To discuss the efficacy and safety profiles of different anti-glaucoma drug classes.
  • To provide evidence-based treatment pathways for various pediatric glaucoma types.

Main Methods:

  • Evidence-based review of existing literature on pediatric glaucoma pharmacotherapy.
  • Analysis of drug classes including adrenoceptor blockers, carbonic anhydrase inhibitors, and prostaglandin analogs.
  • Examination of treatment strategies for specific pediatric glaucoma subtypes.

Main Results:

  • Multiple drug classes are used off-label for pediatric glaucoma, with prostaglandin analogs demonstrating favorable ocular hypotensive effects and fewer systemic side effects.
  • Concerns exist regarding serious side effects, even with topical medications, necessitating measures to minimize systemic absorption.
  • Newer agents like tafluprost show potential but lack pediatric data.

Conclusions:

  • Pharmacotherapy for pediatric glaucoma relies heavily on off-label use, highlighting the need for cautious application and monitoring.
  • Prostaglandin analogs are a preferred option due to their efficacy and safety profile in children.
  • Further research, including studies on newer agents and preservative-free formulations, is essential for advancing pediatric glaucoma management.